Search

everythinglearnresearchcommunity

for

Search:↓

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Avoiding allergens can improve skin and hair conditions in adults with allergic reactions.

People with alopecia areata often have lower vitamin D levels than healthy people.

A 3-year-old boy was diagnosed with a rare, non-scarring hair loss condition called temporal triangular alopecia.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

A premenopausal woman had hair loss and skin issues, treated with topical steroids.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.